Skip to content

EPS (Basic) at other companies

Schrodinger logo
SchrodingerSDGR
-$0.81+1.2%
Certara, Inc. logo
Certara, Inc.CERT
-$0.06-300%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$0.30-160%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$0.29-61.1%
NeoGenomics logo
NeoGenomicsNEO
-$0.13+35.0%
Opko Health logo
Opko HealthOPK
-$0.07+30.0%

Other financials

Income statement

See full
Revenue$24.3M+8.3%
Gross profit$16.1M+23.0%
Operating income$5.6M+108%
Net income$4.5M+47.5%
EPS (diluted)$0.22+46.7%

Balance sheet

See full
Cash & equivalents$25.7M+134%
Total debt$508.0K-36.2%
Total equity$133.8M-29.4%
Total assets$146.5M-27.3%

Cash flow

See full
Operating cash flow$6.4M+13.1%
CapEx$46.0K-30.3%
Free cash flow$6.4M+13.6%

Valuation

See full
Market cap$366.73M+5.2%
Enterprise value$341.51M+6.0%
P/S4.6×+0.2×

Profitability

See full
Gross margin62%+6.7pp
Operating margin-84.3%
Net margin-78%-87.2pp
FCF margin29.5%+14.9pp

Returns & leverage

See full
Return on equity-38.8%-42.8pp
Debt / equity0.0×
Current ratio5.5×+1.1×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Simulations Plus's EPS (basic)?
Simulations Plus (SLP) reported EPS (basic) of $0.22 in Q4 2025.
How has Simulations Plus's EPS (basic) changed year-over-year?
Simulations Plus's EPS (basic) increased by 46.7% year-over-year, from $0.15 to $0.22.
What is the long-term trend for Simulations Plus's EPS (basic)?
Over 4 years (2021 to 2025), Simulations Plus's EPS (basic) has grown at a 60.1% compound annual growth rate (CAGR), from $0.49 to -$3.22.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.